What have genetic studies of rare sequence variants taught us about the aetiology of schizophrenia?
Multifaceted nature of young-onset diabetes - can genomic medicine improve the precision of diagnosis and management?
Pathogenic and likely pathogenic germline variation in patients with myeloid malignancies and their unrelated HLA-matched hematopoietic stem cell donors
Personalised genomic medicine is shaping the future of healthcare
Tumor-associated antigen targets for novel immune-based strategies in prostate cancer
An investigation of the anthropometric measurements in males with 47,XXY (Klinefelter Syndrome) from birth to five years of age and the impact of early hormonal treatment (EHT)
Molecular basis of neurocognitive dysfunction and psychosis in Alpha-Mannosidosis
Exploring the comorbidity between internalizing/externalizing dimensions and cognitive disengagement syndrome through twin studies: a narrative review
New approaches and prospects of immunotherapy and gene therapy for prostate cancer
Silent players, loud impact: unveiling the therapeutic potentials of LncRNAs
Genetics in the diagnosis and treatment of cardiovascular diseases
Challenges in determining the malignant potential of atypical neurofibromas (aNF) using histopathologic features and the potential need for <i>CDKN2A/2B</i> testing: a case report
Reduced protein kinase C delta in a high molecular weight complex in mitochondria and elevated creatine uptake into Barth syndrome B lymphoblasts
The potential therapeutic applications of long non-coding RNAs
Duchenne muscular dystrophy: diagnosis and perspective of treatment
The reactive stroma response regulates the immune landscape in prostate cancer
Unraveling the genetic tapestry of neurodevelopmental disorders: a new horizon
Commentary on “transcription regulation by long non-coding RNAs: mechanisms and disease relevance”
The diagnostic odyssey, clinical burden, and natural history of Barth syndrome: an analysis of patient registry data
In memory of Nathan A. Berger, MD
Fabry nephropathy: focus on podocyte damage and therapeutic target
Risk factors influencing chronic inflammation in neoplastic transition to prostate cancer
The polygenic risk score in the breast cancer treatment
The landscape of current and future therapeutic opportunities for Fabry disease
PNPLA3 as a driver of steatotic liver disease: navigating from pathobiology to the clinics via epidemiology
A novel SNP-based approach for non-invasive prenatal paternity testing using multiplex PCR targeted capture sequencing
The underdiagnosed kidney burden of Fabry disease in females